Following a sharp decline in sales, Swedish medtech company Miris is planning a SEK 20 million rights issue. At the same time ...
A new prostate cancer pill achieved a tumour response in 75 per cent of patients whose tumours could be measured in a phase I ...
Roche’s investigational cancer drug divarasib reduced the risk of death by 44 per cent compared with existing treatments in a phase III trial involving patients with lung cancer.
New treatments for ALS are raising hopes among researchers. “The earlier a patient receives targeted gene therapy, the ...
New treatments for ALS are raising hopes among researchers. “The earlier a patient receives targeted gene therapy, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results